Skip to main content
Clinical Trials/CTRI/2019/06/019896
CTRI/2019/06/019896CompletedNot Applicable

Cross sectional evaluation of growth, metabolic, and psychosocial issues of children with congenital adrenal hyperplasia

Maulana Azad Medical College and Lok Nayak Hospital and GIPMER1 site in 1 country25 target enrollmentStarted: January 7, 2019Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
25
Locations
1
Primary Endpoint
Prevalence of growth abnormalities, metabolic syndrome, pubertal abnormalities

Study Overview

Brief Summary

Congenital adrenal hyperplasia (CAH) is a common disorder (incidence 1:10,000 births) which presents as virilization in girls to life threatening adrenal crisis to milder non-classical forms later in life. To dismay, affected girls with CAH often face social stigma and abandonment to be later adopted by Hijra community. Affected infants may remain unrecognized and may succumb to adrenal crisis in mild infection. Delayed identification may compromise on the height outcomes, metabolic well being and quality of life of patients with CAH. Currently there is lack of data on the follow up outcomes of CAH patients. Hence a screening and monitoring framework is desirable for CAH subjects. Currently there is limited literature available on profile of medical and psychosocial morbidities as retrospective studies have evaluated only on handful of CAH patients. Thus, the current study will highlight the medical and psychosocial issues in patients with CAH for improved case management and health outcomes.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
28.00 Day(s) to 18.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Diagnosed cases of congenital adrenal hyperplasia detected with clinical features of CAH with elevated serum 17-hydroxy progesterone levels.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Prevalence of growth abnormalities, metabolic syndrome, pubertal abnormalities

Time Frame: Single

Secondary Outcomes

  • Association between growth with cumulative steroid doses(Association between growth and serum 17OHP levels)

Investigators

Sponsor
Maulana Azad Medical College and Lok Nayak Hospital and GIPMER
Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials